EX-23.1 2 plx-20211231xex23d1.htm EX-23.1

​ | ​
​ | Exhibit 23.1

​

​

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-230604 and 333-237736) and on Form S-8 (No. 333-148983, No. 333-182677, No. 333-203960, No. 333-225526 and No. 333 239101) of Protalix BioTherapeutics, Inc. of our report dated March 31, 2022 relating to the financial statements, which appears in this Form 10-K.

​

​

​

​

X, 2022 ​ | ​ ​ ​ ​ ​
Tel-Aviv, Israel March 31, 2022 | /s/ Kesselman & Kesselman Certified Public Accountants (lsr.) A member firm of PricewaterhouseCoopers International Limited ​
​ | ​

​

​